
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
about 16 years ago
Will the Newer Oral MS Agents Be Welcomed by Managed Care Organizations?about 16 years ago
The Current Landscape and Unmet Needs in Multiple Sclerosisabout 16 years ago
Participating Facultyabout 16 years ago
Emerging Oral Agents for Multiple Sclerosis


